The market

Every tracked compound, and what the record says about it.

How many human studies exist for each compound, how far they got, and whether any regulator has approved a product built on it. Counts come from ClinicalTrials.gov and Drugs@FDA and are re-checked against the intervention each trial actually registered. Nothing here is a recommendation to take anything.

How this data is collected →

What the public record holds

Compounds checked

68 of 68

Looked up against ClinicalTrials.gov and Drugs@FDA on Aug 2, 2026

With an approved product

19

49 have no FDA-approved product containing them

No human study at all

25

Not one registered trial on ClinicalTrials.gov names them as an intervention. See which · Why clinic prices differ

Registered studies counted

3,186

Across every tracked compound, verified against the intervention named in each trial

Ordered by the count of registered human studies whose intervention names the compound. Counting studies, not weighing what they found.

Every tracked compound, and what the record says about it.Study counts include only trials whose registered intervention names the compound — the registry search is fuzzy, so every match is re-checked. FDA status means an approved product exists whose active ingredient is that compound. Neither is a statement about whether anything works or is safe.Every column is here — slide the table sideways to read the rest, or open it on a wider screen.
#WatchlistCompoundCategoryFDA statusapproved product existsHuman studiesregistered on ClinicalTrials.govEvidencehow much is knownReadershipWikipedia readers / month
5OxytocinOXYTSexual & hormonalApprovedOXYTOCIN648 studiesto phase 4A · Strong — An approved product exists25,916readers / month
1SemaglutideSEMAMetabolic & weight lossApprovedWEGOVY589 studiesto phase 4A · Strong — An approved product exists54,466readers / month
20LiraglutideLIRAMetabolic & weight lossApprovedVICTOZA442 studiesto phase 4A · Strong — An approved product exists4,759readers / month
26ExenatideEXENMetabolic & weight lossApprovedBYETTA279 studiesto phase 4A · Strong — An approved product exists3,088readers / month
3TirzepatideTIRZMetabolic & weight lossApprovedZEPBOUND222 studiesto phase 4A · Strong — An approved product exists38,322readers / month
33TeriparatideTERIBone & digestiveApprovedTERIPARATIDE145 studiesto phase 4A · Strong — An approved product exists2,243readers / month
28DulaglutideDULAMetabolic & weight lossApprovedTRULICITY115 studiesto phase 4A · Strong — An approved product exists2,756readers / month
8GlutathioneGSHNote: 267 loose registry matches, 72 confirmedLongevity & cellularResearch onlyno FDA approval72 studiesto phase 4B · Moderate — Reached phase 3 or 4, not approved14,776readers / month
7NAD+NADNote: 260 loose registry matches, 71 confirmedLongevity & cellularResearch onlyno FDA approval71 studiesto phase 4B · Moderate — Reached phase 3 or 4, not approved19,297readers / month
51LixisenatideLIXIMetabolic & weight lossApprovedSOLIQUA 100/3366 studiesto phase 4A · Strong — An approved product exists462readers / month
44PramlintidePRAMMetabolic & weight lossApprovedSYMLIN54 studiesto phase 4A · Strong — An approved product exists628readers / month
56Thymosin alpha-1TA1Immune & inflammationResearch onlyno FDA approval50 studiesto phase 4B · Moderate — Reached phase 3 or 4, not approved54readers / month
49TeduglutideTEDUBone & digestiveApprovedGATTEX KIT41 studiesto phase 4A · Strong — An approved product exists556readers / month
24CerebrolysinCEREBCognitive, mood & sleepResearch onlyno FDA approval39 studiesto phase 4B · Moderate — Reached phase 3 or 4, not approved3,642readers / month
27CagrilintideCAGRMetabolic & weight lossResearch onlyno FDA approval39 studiesto phase 3B · Moderate — Reached phase 3 or 4, not approved2,936readers / month